US 10106556
Heterocyclic compound
granted A61KA61K31/454A61K31/4709
Quick answer
US patent 10106556 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/454, A61K31/4709, A61K31/538, A61K31/5383